Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
15.83B | 16.55B | 8.64B | 3.91B | 1.33B | 376.03M | Gross Profit |
10.70B | 12.02B | 6.59B | 3.11B | 1.03B | 259.18M | EBIT |
6.74B | 8.41B | 4.58B | 2.10B | 563.07M | 3.29M | EBITDA |
6.78B | 8.46B | 4.61B | 2.10B | 563.14M | 6.70M | Net Income Common Stockholders |
4.71B | 5.79B | 2.65B | 1.33B | 368.16M | 4.25M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
10.45B | 10.17B | 7.43B | 3.98B | 1.18B | 555.97M | Total Assets |
12.33B | 12.00B | 8.33B | 4.23B | 1.35B | 617.87M | Total Debt |
47.55M | 58.76M | 101.71M | 136.30M | 150.06M | 145.00M | Net Debt |
-10.40B | -10.12B | -7.33B | -3.85B | -1.03B | -410.97M | Total Liabilities |
2.20B | 2.98B | 2.73B | 1.30B | 575.81M | 208.26M | Stockholders Equity |
10.13B | 9.02B | 5.60B | 2.93B | 777.77M | 409.61M |
Cash Flow | Free Cash Flow | ||||
0.00 | 5.32B | 3.90B | 2.06B | 653.47M | 12.04M | Operating Cash Flow |
0.00 | 5.48B | 3.96B | 2.08B | 678.97M | 15.88M | Investing Cash Flow |
0.00 | -308.34M | -400.20M | -79.29M | -57.29M | -34.29M | Financing Cash Flow |
0.00 | -2.43B | -110.48M | 804.89M | -347.00K | 443.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥79.83B | 18.91 | ― | 17.96% | -2.21% | ||
64 Neutral | $12.67B | 9.74 | 7.58% | 17015.08% | 12.21% | -6.96% | |
$1.46B | ― | -9.01% | 1.11% | ― | ― | ||
$1.57B | 20.96 | 23.83% | 4.05% | ― | ― | ||
66 Neutral | ¥19.08B | 25.58 | 1.09% | 46.09% | 24.93% | ||
¥38.30B | 24.31 | 3.70% | ― | ― | |||
74 Outperform | ¥1.32T | 29.33 | 1.68% | 24.10% | 11.27% |
M&A Research Institute Holdings Inc. announced corrections to its previously released financial results for the six months ended March 31, 2025. The corrections pertain to a partial error in the description of the consolidated earnings forecasts for the fiscal year ending September 30, 2025. The revised figures indicate no change in net sales and profits, but a slight adjustment in net income per share from 67.45 yen to 67.65 yen, which may have implications for stakeholders’ financial expectations.
M&A Research Institute Holdings Inc. has announced a revision to its dividend policy, aiming to enhance shareholder value by initiating dividend payments. This change is intended to reduce stock price volatility and appropriately return surplus cash to shareholders, while balancing shareholder returns with sustainable growth and future investment opportunities.
M&A Research Institute Holdings Inc. has announced a decision by its Board of Directors to repurchase up to 7,500,000 of its own shares, representing 12.81% of the total issued shares, from May 1 to September 30, 2025. This move is intended to allocate shares for stock options for officers and employees and to implement a flexible capital policy in response to the current business environment, as well as to address the belief that the current stock price does not adequately reflect future profitability.
M&A Research Institute Holdings Inc. has revised its full-year consolidated earnings forecast for the fiscal year ending September 2025 due to increased deal cancellations in its M&A brokerage business, resulting in lower than expected transaction completions. Despite efforts to improve productivity, the company anticipates a significant decrease in revenue and income compared to previous forecasts, impacting its financial performance and stakeholder expectations.
M&A Research Institute Holdings Inc. reported a significant decline in its financial performance for the six months ending March 31, 2025, with net sales and profits dropping by over 10% and 50% respectively compared to the previous year. Despite the downturn, the company expanded its operations by including two new subsidiaries, M&A Research Institute Singapore Pte. Ltd. and Soken Lease Co., Ltd., potentially positioning itself for future growth in the international market.